Cargando…

Cell and animal models of SARS-CoV-2 pathogenesis and immunity

The spread of the novel virus SARS coronavirus 2 (SARS-CoV-2) was explosive, with cases first identified in December 2019, and >22 million people infected and >775,000 deaths as of August 2020. SARS-CoV-2 can cause severe respiratory disease in humans leading to coronavirus disease 2019 (COVID...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leist, Sarah R., Schäfer, Alexandra, Martinez, David R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Company of Biologists Ltd 2020
Materias:	Special Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7490513/ https://www.ncbi.nlm.nih.gov/pubmed/32887790 http://dx.doi.org/10.1242/dmm.046581

Ejemplares similares

Animal models for SARS-CoV-2 and SARS-CoV-1 pathogenesis, transmission and therapeutic evaluation
por: Saravanan, Udhaya Bharathy, et al.
Publicado: (2022)

High Potency of a Bivalent Human V(H) Domain in SARS-CoV-2 Animal Models
por: Li, Wei, et al.
Publicado: (2020)

Distinct Molecular Mechanisms Characterizing Pathogenesis of SARS-CoV-2
por: Lee, Su Jin, et al.
Publicado: (2022)

SARS-CoV-2 Variants and Vaccines
por: Krause, Philip R., et al.
Publicado: (2021)

Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection
por: Li, Wei, et al.
Publicado: (2020)

Animal models for SARS-CoV-2
por: Lee, Chung-Young, et al.
Publicado: (2021)

Tocilizumab in patients infected by SARS-CoV2()
por: Sancho, Milagros, et al.
Publicado: (2021)

Therapeutische Nanobodies gegen SARS-CoV-2
por: Güttler, Thomas, et al.
Publicado: (2022)

Air contamination with SARS-CoV-2 in the operating room
por: Hirota, Kazuyoshi
Publicado: (2020)

Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice
por: Pruijssers, Andrea J., et al.
Publicado: (2020)

Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models
por: Khoury, David S., et al.
Publicado: (2020)

Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice
por: Martinez, David R., et al.
Publicado: (2021)

Cardiovascular disease in SARS‐CoV‐2 infection
por: Sato, Kei, et al.
Publicado: (2021)

Strategies used for the COVID-OUT decentralized trial of outpatient treatment of SARS-CoV-2
por: Avula, Nandini, et al.
Publicado: (2023)

The mutational spectrum of SARS-CoV-2 genomic and antigenomic RNA
por: Zhao, Lele, et al.
Publicado: (2022)

Interpretation of laboratory tests for prevention of the SARS-CoV-2 transmission
por: Masui, Kenichi
Publicado: (2020)

Control of SARS-CoV-2 transmission in orthodontic practice
por: Guo, Yongwen, et al.
Publicado: (2020)

The interplay of SARS-CoV-2 and Clostridioides difficile infection
por: Khanna, Sahil, et al.
Publicado: (2021)

SARS-CoV-2 placentitis, stillbirth, and maternal COVID-19 vaccination: clinical–pathologic correlations
por: Schwartz, David A., et al.
Publicado: (2023)

A Comprehensive Review of Animal Models for Coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoV
por: Singh, Ashutosh, et al.
Publicado: (2020)

Assessment of Specimen Pooling to Conserve SARS CoV-2 Testing Resources
por: Abdalhamid, Baha, et al.
Publicado: (2020)

Animal models of SARS-CoV-2 transmission
por: de Vries, Rory D, et al.
Publicado: (2021)

Animal models and vaccines for SARS-CoV infection
por: Roberts, Anjeanette, et al.
Publicado: (2008)

A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures
por: Dinnon, Kenneth H., et al.
Publicado: (2020)

Relevance of immune response and vaccination strategies of SARS-CoV-2 in the phase of viral red queen dynamics
por: Jacob, Jobin John, et al.
Publicado: (2021)

COVID-19 in Children and Safety of SARS-CoV-2 Immunization in Children: Statement of the International Pediatric Association
por: Thacker, Naveen, et al.
Publicado: (2021)

Bioinformatical study on the proteomics and evolution of SARS-CoV
por: Liu, Shuqun, et al.
Publicado: (2003)

The Coronaviruses of Animals and Birds: Their Zoonosis, Vaccines, and Models for SARS-CoV and SARS-CoV2
por: Alluwaimi, Ahmed M., et al.
Publicado: (2020)

Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections
por: Fani, Mona, et al.
Publicado: (2020)

Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection
por: Graham, Jessica B., et al.
Publicado: (2020)

Prospects of animal models and their application in studies on adaptive immunity to SARS-CoV-2
por: Wei, Xiaohui, et al.
Publicado: (2022)

Current status of therapeutic approaches and vaccines for SARS-CoV-2
por: Wahid, Braira, et al.
Publicado: (2021)

Proteomics research of SARS-CoV-2 and COVID-19 disease
por: Zhang, Nan, et al.
Publicado: (2022)

SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19
por: Gusev, Evgenii, et al.
Publicado: (2022)

An outline of SARS-CoV-2 pathogenesis and the complement cascade of immune system
por: Hembram, Padmalochan
Publicado: (2021)

SARS-CoV-2 and Chlamydia pneumoniae co-infection: A review of the literature
por: Frutos, María Celia, et al.
Publicado: (2022)

A Mouse Model of SARS-CoV-2 Infection and Pathogenesis
por: Sun, Shi-Hui, et al.
Publicado: (2020)

SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models
por: Kanimozhi, G., et al.
Publicado: (2021)

SARS-CoV-2 in animals: From potential hosts to animal models
por: Michelitsch, Anna, et al.
Publicado: (2021)

In Vitro and Animal Models for SARS-CoV-2 research
por: Takayama, Kazuo
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p7oofjp3k2ah89va20dms61gim